"Nature is healing" — but $MRNA -4.2% says otherwise.
KOD+137KOD+137ABVX +3.9% is noise.
One has a catalyst, one is just a bounce. Know the difference. Follow me.
The last rule is the one that pays: let the market test support first. Most people don’t lose on bad picks — they lose on early entries. October is volatile; opportunities come only if you still have cash.
This week’s plan is :
- Follow your plan
- Do not FOMO
- Don’t gamble on earnings
- Let the market test support levels before you buy
Stay locked in.
October will be a month of attractive opportunities.
$NVAX broke its wedge and reclaimed the 200WMA — technically stronger. But the test is a higher low above $10. Still unprofitable, revenue tied to government contracts. The 71% to wedge top is theoretical and needs volume.
$NVAX Looking strong 👀
Price up 4% today and is firmly above the trendline. I want to see higher highs form next.
I expect this to move well in coming months.
71% upside to the top of the wedge. 🚀
Cohen's $GME warrants expire Oct 30 at a $32 strike. Stock is ~$21 — unless it rallies 50%+ before then, those warrants expire worthless. His Sept 10 share buy is separate.
Nasdaq at an all-time high is strong — but what matters isn't the size of the move, it's how broad the rally is. If only a few heavyweights are pulling it, be more cautious, not less.
The key for $ALAB isn’t just “strength returning” — it’s that price is testing the descending trendline drawn from the highs. The green circle marks that exact test. Real confirmation needs a close above that line with volume behind it.